Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biosynthetics dominate orthopaedics in 1996

This article was originally published in Clinica

Executive Summary

Clinical orthopaedics is reaping the benefits of the research of the late eighties that attempted to characterise with increasing accuracy the mineral content and lattice structure of bone. The materials produced are used as back fill for autografts, to fill interstices resulting from osteoporotic fractures and to provide the cement and filler required during joint replacement procedures. The industry is also moving to incorporate growth factors in these materials to speed new bone growth and repair.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT083375

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel